Cradle is at the forefront of protein engineering and AI technology, allowing scientific teams to engineer proteins faster and more efficiently. With a focus on leveraging AI, Cradle generates protein candidates and enhances their properties, resulting in more breakthroughs with fewer experimental rounds. This process is guided by the user's own experimental data, empowering teams to streamline their workflows significantly.
Companies such as Novo Nordisk, Johnson & Johnson, and IFF leverage Cradle's innovative platform to achieve superior protein optimization. The AI-powered design tools enable users to craft highly effective solutions across various applications, including therapeutics, agricultural innovations, and food ingredient development. By ensuring private, secure access to experimental data, Cradle guarantees that only the authorized team can utilize their proprietary information without any risk of data being used to train models for other organizations, giving them full control over their intellectual property.